logo

Argenx Se (ARGX)



Trade ARGX now with
  Date
  Headline
12/15/2020 10:47:06 AM Argenx Stock Breaches $300 Mark
11/23/2020 1:05:48 AM Argenx Agrees To Buy FDA Priority Review Voucher From Bayer Healthcare Pharmaceuticals For $98 Mln
10/5/2020 1:14:09 AM Argenx Presents New Data From Pivotal Phase 3 ADAPT Trial Evaluating Efgartigimod
5/29/2020 1:08:44 AM Argenx Reports Full Exercise Of Underwriters' Option To Purchase Addl ADSs
5/28/2020 12:25:42 AM Argenx Announces Pricing Of $750 Mln Of Global Offering Of Ordinary Shares
5/26/2020 1:09:50 AM Argenx Reports Positive Topline Data From Pivotal ADAPT Trial Of Efgartigimod
2/4/2019 1:02:11 AM Argenx, Halozyme Therapeutics Enter Global Collaboration And License Agreement For ENHANZE Technology
12/17/2018 2:31:47 AM Forbion Portfolio Company Staten Biotechnology Enters Into Collaboration With Novo Nordisk
12/4/2018 7:49:18 AM Wedbush Reiterates argenx SE (ARGX) At Outperform With $131 Up From $130 Price Target
12/3/2018 1:02:31 AM Argenx Enters Global Collaboration And License Agreement With Cilag GmbH International For Cusatuzumab (ARGX-110)
12/3/2018 1:01:46 AM Argenx Provides Detailed Data From Phase 2 Clinical Trial Of Efgartigimod In Immune Thrombocytopenia
11/5/2018 6:53:28 AM Wedbush Reiterates argenx SE (ARGX) At Outperform With $130 Up From $125 Price Target
9/20/2018 6:43:14 AM Wedbush Reiterates argenx SE (ARGX) At Outperform With $125 Up From $121 Price Target